Loughborough’s life sciences hub Charnwood Campus in the UK has recommissioned its synthetic and chemistry research facility to cater to the needs of pre-clinical discovery contract research organisation (CRO) Charnwood Molecular. It will cost £54 million.
The new laboratories will provide capacity for future growth and expansion of Charnwood Molecular’s medicinal chemistry and process research teams, as well as facilitate the addition of drug discovery service lines.
Charnwood Campus Commercial Director Gosia Khrais said: “We are lucky to have a forward-thinking and business- and community-orientated council, as well as an open-minded and ambitious LLEP. Over the years, we have received a lot of positive feedback from local businesses and Loughborough residents. We are very humbled and grateful for that support, and we will continue to work tirelessly to facilitate job creation, accelerate economic growth and play our part in the Covid recovery effort.”
